Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;48:460-466
Published online before print July 17, 2006, doi: 10.1161/01.HYP.0000233018.60736.70
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
48/3/460    most recent
01.HYP.0000233018.60736.70v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gudbrandsen, O. A.
Right arrow Articles by Iversen, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gudbrandsen, O. A.
Right arrow Articles by Iversen, B. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*OLEIC ACID
*PROSTAGLANDIN F2ALPHA
Related Collections
Right arrow Lipids
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Other Treatment
Right arrow Lipid and lipoprotein metabolism

(Hypertension. 2006;48:460.)
© 2006 American Heart Association, Inc.


Original Articles

Prevention of Hypertension and Organ Damage in 2-Kidney, 1-Clip Rats by Tetradecylthioacetic Acid

Oddrun Anita Gudbrandsen; Michael Hultstrøm; Sabine Leh; Liliana Monica Bivol; Øyvind Vågnes; Rolf K. Berge; Bjarne M. Iversen

From the Lipid Research Group (O.A.G., R.K.B.) and Renal Research Group (M.H., S.L., L.M.B., Ø.V., B.M.I.), Institute of Medicine, University of Bergen, Bergen Norway; and the Department of Pathology (S.L.), Haukeland University Hospital, Bergen, Norway.

Correspondence to Bjarne M. Iversen, Renal Research Group, Institute of Medicine, University of Bergen, N-5021 Bergen, Norway. E-mail: Bjarne.Iversen{at}med.uib.no

Dietary lipids are reported to affect the blood pressure in both humans and experimental animal models with hypertension. In the present study, 2-kidney, 1-clip (2K1C) hypertensive rats were treated with the modified fatty acid tetradecylthioacetic acid (TTA) from the time of clipping or after hypertension was established. TTA treatment attenuated the development of hypertension and reduced established 2K1C hypertension. The mRNA level of renin in the clipped kidney and the plasma renin activity were markedly reduced, and the plasma angiotensin II level tended to decrease after TTA treatment. In addition, TTA reduced the mRNA level of angiotensinogen in white adipose tissue. Prevention of organ damage was demonstrated by normal urinary excretion of protein, maintained serum albumin, lower heart weight, and clearly reduced vascular, glomerular, and tubulointerstitial damage in the nonclipped kidney. Renal function was not affected as estimated by unchanged plasma creatinine. Furthermore, the serum levels of triacylglycerol and cholesterol were reduced by TTA. The serum fatty acid composition was changed, resulting in a favorable increase of oleic acid. However, the levels of all of the omega-3 fatty acids and of linoleic acid were reduced, and no change was seen in the level of arachidonic acid, but the urinary excretion of 8-iso-prostaglandin F2{alpha} was declined. In conclusion, TTA attenuated the development of hypertension, reduced established hypertension, and prevented the development of organ damage in 2K1C rats, possibly by reducing the amounts of the vasoconstrictors angiotensin II and 8-iso-prostaglandin F2{alpha} and by inducing a favorable increase of oleic acid in serum.


Key Words: renin-angiotensin system • renal disease • fatty acids




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Bivol, M. Hultstrom, O. A. Gudbrandsen, R. K. Berge, and B. M. Iversen
Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1866 - R1873.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R438 - R447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. M. Bivol, R. K. Berge, and B. M. Iversen
Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845.
[Abstract] [Full Text] [PDF]